Clearline Capital’s NuVasive, Inc. NUVA Stock Holding History

Clearline Capital’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-57,488	Closed	-$3.24M	–	146
2020 Q4	$3.24M	Buy	+57,488	New	+$2.83M	0.72%	43

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Clearline Capital's NUVA Position: Q1 2021 in Review

Clearline Capital sold out of NuVasive, Inc. (NUVA) in Q1 2021, closing a stake of 57,488 shares — an estimated $3.24M sold.

Clearline Capital first reported a position in NUVA in Q4 2020 and held it in 1 quarter. The position peaked at $3.24M in Q4 2020. 261 funds tracked by Wall St. Rank hold NUVA as of Q1 2021.

Clearline Capital reported no remaining NuVasive, Inc. position as of Q1 2021 after selling out during the quarter.
Clearline Capital sold 57,488 NuVasive, Inc. shares in Q1 2021, an estimated $3.24M.
Clearline Capital first reported a position in NuVasive, Inc. in Q4 2020 and held it in 1 quarter.
Clearline Capital's NuVasive, Inc. position peaked at $3.24M in Q4 2020.
261 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2021.

Based on Clearline Capital's 13F filing for Q1 2021, filed 17 May 2021.